Alterations in serum levels of fetuin A and selenoprotein P in chronic hepatitis C patients with concomitant type 2 diabetes: A case-control study

Clinics and Research in Hepatology and Gastroenterology
Sahar A AliDalia H A Abdelaziz

Abstract

Insulin resistance (IR) and type 2 diabetes mellitus (T2DM) are serious extrahepatic manifestations of chronic hepatitis C virus (HCV) infection. However, the mechanism underlying the IR in chronic HCV is obscure. Hepatokines are group of liver-derived protein, which affect the glucose and lipid metabolism in several tissues. Fetuin A (also known as human α2-HS-glycoprotein) is one of the hepatokines, which was recognized as a natural inhibitor of the insulin receptor tyrosine kinase in liver and skeletal muscle. Additionally, selenoprotein P has emerged as an important hepatokine, which primarily acts as selenium transporter and has been reported to be implicated in glucose homeostasis in human. The aim of the current case-control study was to investigate the serum levels of both fetuin A and selenoprotein P in chronic hepatitis C patients with or without T2DM and to correlate their levels with other biochemical parameters of insulin resistance. Our results showed that, serum fetuin A levels increased significantly in HCV patients compared with controls (P<0.01) and surplus increase was found in HCV with concomitant T2DM (P>0.001). However, selenoprotein P levels significantly elevated only in patients with both HCV and T2DM (...Continue Reading

References

Dec 3, 2003·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Serhat AytugNajma Begum
Nov 8, 2007·Biochemical and Biophysical Research Communications·Philippe L WalterLars-Oliver Klotz
Jul 10, 2008·JAMA : the Journal of the American Medical Association·Joachim H IxUNKNOWN Health ABC Study
Oct 31, 2008·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Bodo SpeckmannHolger Steinbrenner
Nov 3, 2010·Cell Metabolism·Hirofumi MisuShuichi Kaneko
Jul 28, 2011·Virology Journal·Eman I ElhawaryMohamed Abdel-Hamid
Feb 2, 2012·World Journal of Gastroenterology : WJG·Abdel-Rahman El-Zayadi, Mahmoud Anis
Nov 23, 2012·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Khayriyyah Mohd HanafiahSteven T Wiersma
Jan 23, 2013·Nature Reviews. Endocrinology·Norbert Stefan, Hans-Ulrich Häring
Jan 26, 2013·Clinical Chemistry and Laboratory Medicine : CCLM·Toshio OkazakiHiroshi Yotsuyanagi
Jul 3, 2013·Diabetes & Vascular Disease Research : Official Journal of the International Society of Diabetes and Vascular Disease·Chan-Hee JungJi-Oh Mok
Mar 4, 2014·Hepatology International·Alessandra Mangia, Maria Ripoli

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.